Patent Assignment
Reel/Frame 065658/0369
Change of Name
Recorded: 2023-11-21
Pages: 2
Assignor
HUIGENE THERAPEUTICS CO., LTD.
Executed: 2023-01-28
Assignee
HUIDAGENE THERAPEUTICS CO., LTD.
ROOM 1002, BUILDING #7-1, NO. 160 BASHENG ROAD, PUDONG DISTRICT, SHANGHAI, 201203, CHINA
Covered Property
(1)
Engineered Crispr/CAS13 System and Uses Thereof
Application:
17/836,266 →
Publication:
US 2023/0075045
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 29, 2023
From: WANG, XING; WANG, SHAORAN; YAO, XUAN; SHI, LINYU
To: HUIGENE THERAPEUTICS CO., LTD.
Reel/Frame 064108/0245 →
Assignment of Assignor's Interest
Nov 22, 2023
From: HUIDAGENE THERAPEUTICS CO., LTD.
To: HUIDAGENE THERAPEUTICS (SINGAPORE) PTE. LTD.
Reel/Frame 065646/0545 →